|
Patient numbers in PDE-5 inhibitor trials (by world region) |
|||
| Region |
Sildenafil |
Tadalafil |
Vardenafil |
|
|
|||
| Europe |
2040 |
839 |
309 |
| North America |
2486 |
546 |
1658 |
| South America |
631 |
0 |
0 |
| Asia |
1026 |
0 |
279 |
| Africa |
254 |
0 |
0 |
| Australia |
63 |
0 |
0 |
| World |
0 |
0 |
448 |
| Europe and North America |
217 |
651 |
580 |
| Europe and Australia |
349 |
0 |
0 |
Moore et al. BMC Urology 2005 5:18 doi:10.1186/1471-2490-5-18 |
|||